An evidence-based approach to the assessment and management of Polycystic Ovary Syndrome

Register here

2025 dates

6-week access blocks:

  • 7 April - 19 May
  • 26 May - 30 June

Fees

General attendee: $90

Discounted rate: $80

Available for Frequent Flyer Discount if you have done one of our other courses (online or face-to- face)

Cancellation & Transfer Policy

We understand that sometimes plans change. Please read our cancellation policy here

Enquiries:

mchri.shortcourses@monash.edu

PCOS Short Course Overview

This course is aimed at health professionals and provides a comprehensive, evidence-based approach to the assessment and management of Polycystic Ovary Syndrome (PCOS), based on the 2023 International Evidence-Based Guideline.

At the completion of the course you should have greater understanding of the assessment and management of PCOS based on the guidelines.

Course Duration and Structure

  • A self-paced 3-week course requiring approximately 3 hours of study per week.
  • Flexible access to course materials for 6 weeks, allowing completion at an accelerated pace if desired.

Facilitation and Resources

  • Led by experts who developed and assisted in the development of the 2023 PCOS guidelines.
  • Includes videos, additional resources and interactive quizzes every week
  • Curriculum aims to provide clinicians with the skills to diagnosis, treat and management guided by the 2023 PCOS guidelines.

Who will benefit?

  • Ideal for healthcare professionals in the management and treatment of polycystic ovarian syndrome (PCOS).
  • Beneficial for General Practitioners, Specialists (gynaecologists, endocrinologists, psychologists), Nurses, and Allied Health
    Professionals (dietitians, exercise physiologists).
  • Suitable for those seeking to deepen PCOS knowledge, improve diagnostic techniques, and align treatment with the latest
    guidelines.

Learning Outcomes

  1. Recognise the signs and symptoms of PCOS.
  2. Develop skills in refined evidence-based assessments and management plans aligned with the International evidence-based clinical guideline 2023.
  3. Utilise evidence-based tools for assessing and referring emotional, psychological, and psychosexual support for women with PCOS.